Pharmacotherapeutic management of acute alcohol withdrawal syndrome in critically Ill patients |
| |
| Authors: | A. Glahn P. J. Proskynitopoulos S. Bleich T. Hillemacher |
| |
| Affiliation: | 1. Department of Psychiatry, Psychotherapy and Social Psychiatry, Hannover Medical School , Hannover, Germany glahn.alexander@mh-hannover.de;3. Department of Psychiatry, Psychotherapy and Social Psychiatry, Hannover Medical School , Hannover, Germany;4. Department of Psychiatry, Psychotherapy and Social Psychiatry, Hannover Medical School , Hannover, Germany;5. Department of Psychiatry and Psychotherapy, Paracelcus Medical University , Nuremberg, Germany |
| |
| Abstract: | ![]()
ABSTRACT Introduction Alcohol withdrawal syndrome is a common and life-threatening condition in patients suffering from alcohol use disorder. Treatment of this syndrome is challenging, especially in patients that are critically ill, either because of withdrawal symptoms or underlying conditions. For the treatment, several pharmacological agents exist, such as benzodiazepines, barbiturates, or dexmedetomidine. Nonetheless, as alcohol withdrawal syndromes can occur in every clinical setting, it is necessary to provide a guideline for clinicians confronted with this syndrome in varying clinical contexts. |
| |
| Keywords: | Alcohol withdrawal syndrome psychopharmacotherapy alcohol use disorder critically Ill |
|
|
